Experiences of genetic counseling for BRCA1/2 among recently diagnosed breast cancer patients: A qualitative inquiry

Journal of Psychosocial Oncology

Volumn 26, Issue 4, 2008, Pages 33-52

  Vadaparampil, Susan T ^a,b   Quinn, Gwendolyn P ^a,b   Brzosowicz, Jennifer Pickard ^b   Miree, Cheryl A ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Breast cancer; Educational needs; Genetic counseling; Genetic testing; Qualitative

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL DECISION MAKING; EXPERIENCE; FAMILY HISTORY; FEMALE; GENETIC COUNSELING; HUMAN; HUMAN TISSUE; INFORMATION; ONCOGENE; QUALITATIVE ANALYSIS; SATISFACTION; ATTITUDE TO HEALTH; BREAST TUMOR; GENETICS; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; TUMOR SUPPRESSOR GENE;

ATTITUDE TO HEALTH; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; HUMANS; MIDDLE AGED; QUESTIONNAIRES;

EID: 65749150416     PISSN: 07347332     EISSN: 15407586     Source Type: Journal    
DOI: 10.1080/07347330802359586     Document Type: Article

References (35)

1. Aita, V., McIlvain, H., Susman, J., & Crabtree, B. (2003). Using metaphor as a qualitative analytic approach to understand complexity in primary care research. Qualitative Health Research, 13(10), 1419-1431.
2. American Medical Association (2001). Identifying and managing hereditary risk for breast and ovarian cancer. Chicago, IL: American Medical Association.
3. Armstrong, K., Stopfer, J., Calzone, K., Fitzgerald, G., Coyne, J., & Weber, B. (2002). What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations. Genetic Testing, 6(2), 115-118.
4. Braithwaite, D., Emery, J., Walter, F., Prevost, A. T., & Sutton, S. (2004). Psychological impact of genetic counseling for familial cancer: A systematic review and meta-analysis. Journal of the National Cancer Institute, 96(2), 122-133.
5. Brown, K. L., Hutchison, R., Zinberg, R. E., & McGovern, M. M. (2005). Referral and experience with genetic testing among women with early onset breast cancer. Genetic Testing, 9(4), 301-305.
6. Butow, P. N., Lobb, E. A., Meiser, B., Barratt, A., & Tucker, K. M. (2003). Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: A systematic review. The Medical Journal of Australia, 178(2), 77-81.
7. Charles, S., Kessler, L., Stopfer, J. E., Domchek, S., & Halbert, C. H. (2006). Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women. Patient Education and Counseling, 63(1/2), 196-204.
8. Chen, W. Y., Garber, J. E., Higham, S., Schneider, K. A., Davis, K. B., Deffenbaugh, A. M., et al. (2002). BRCA1/2 genetic testing in the community setting. Journal of Clinical Oncology, 20(22), 4485-4492.
9. Daly, M. B. (2004). Tailoring breast cancer treatment to genetic status: The challenges ahead. Journal of Clinical Oncology, 22(10), 1776-1777.
10. Daly, M., Axilbund, J. E., Bryant, E., Buys, S., Eng, C., Friedman, S., et al. (2006). The NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian Clinical Practice Guideline, version 1.2006. Retrieved November 19, 2006, from http://nccn.org/ physiciangls/indiex.html. Most recent and complete version of guideline can be obtained at to www.nccn.org.
11. Fatouros, M., Baltoyiannis, G., & Roukos, D. H. (2008). the predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Annals of Surgical Oncology, 15(1), 21-33.
12. Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., et al. (1998). Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Journal of the National Cancer Institute, 90(18), 1371-1388.
13. Fisher, B., Dignam, J., Bryant, J., DeCillis, A., Wickerham, D. L., Wolmark, N., et al. (1996). Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. Journal of the National Cancer Institute, 88(21), 1529-1542.
14. Hamann, H. A., Somers, T. J., Smith, A. W., Inslicht, S. S., & Baum, A. (2005). Posttraumatic stress associated with cancer history and BRCA1/2 genetic testing. Psychosomatic Medicine, 67(5), 766-772.
15. Hampel, H., Sweet, K., Westman, J. A., Offit, K., & Eng, C. (2004). Referral for cancer genetics consultation: A review and compilation of risk assessment criteria. Journal of Medical Genetics, 41(2), 81-91.
16. Hartmann, L. C., Schaid, D. J.,Woods, J. E., Crotty, T. P., Myers, J. L., Arnold, P. G., et al. (1999). Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. New England Journal of Medicine, 340(2), 77-84.
17. Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., et al. (2001). Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. Journal of the National Cancer Institute, 93(21), 1633-1637.
18. Jacobs, L. A., & Giarelli, E. (2004). A model of survivorship in cancer genetic care. Seminars in Oncology Nursing, 20(3), 196-202.
19. Lerman, C., Croyle, R. T., Tercyak, K. P., & Hamann, H. (2002). Genetic testing: Psychological aspects and implications. Journal of Consulting and Clinical Psychology, 70(3), 784-797.
20. Lynch, H. T., Lemon, S. J., Durham, C., Tinley, S. T., Connolly, C., Lynch, J. F., et al. (1997). A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer, 79(11), 2219-2228.
21. Matloff, E. T. (2000). The breast surgeon's role in BRCA1 and BRCA2 testing. American Journal of Surgery, 180(4), 294-298.
22. Meijers-Heijboer, H., van Geel, B., van Putten, W. L., Henzen-Logmans, S. C., Seynaeve, C., Menke-Pluymers, M. B., et al. (2001). Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. New England Journal of Medicine, 345(3), 159-164.
23. Meiser, B. (2005). Psychological impact of genetic testing for cancer susceptibility: An update of the literature. Psychooncology, 14(12), 1060-1074.
24. Nelson, H. D., Huffman, L. H., Fu, R., & Harris, E. L. (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Systematic evidence review for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 143(5), 362-379.
25. O'Neill, S. M., Peters, J. A., Vogel, V. G., Feingold, E.,&Rubinstein,W. S. (2006). Referral to cancer genetic counseling: Are there stages of readiness? American Journal of Medical Genetics: Part C, Seminars in Medical Genetics, 142(4), 221-231.
26. Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van 't Veer, L., Garber, J. E., et al. (2004). Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group. Journal of Clinical Oncology, 22(6), 1055-1062.
27. Schwartz, M. D., Kaufman, E., Peshkin, B. N., Isaacs, C., Hughes, C., DeMarco, T., et al. (2003). Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. Journal of Clinical Oncology, 21(21), 4034-4041.
28. Schwartz,M. D., Lerman, C., Brogan, B., Peshkin, B. N., Halbert, C. H., DeMarco, T., et al. (2004). Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. Journal of Clinical Oncology, 22(10), 1823-1829.
29. Schwartz, M. D., Lerman, C., Brogan, B., Peshkin, B. N., Isaacs, C., DeMarco, T., et al. (2005).Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiology, Biomarkers & Prevention, 14(4), 1003-1007.
30. Stolier, A. J., Fuhrman, G. M., Mauterer, L., Bolton, J. S.,& Superneau,D.W. (2004). Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation. The Breast Journal, 10(6), 475-480.
31. Tercyak, K. P., Demarco, T. A., Mars, B. D., & Peshkin, B. N. (2004).Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: Psychological aspects. American Journal of Medical Genetics: Part A, 131(1), 36-41.
32. Toubassi, D., Himel, D.,Winton, S., & Nyhof-Young, J. (2006). The informational needs of newly diagnosed cervical cancer patientswho will be receiving combined chemoradiation treatment. Journal of Cancer Education, 21(4), 263-268.
33. Vadaparampil, S. T., Miree, C. A., Wilson, C., & Jacobsen, P. B. (2007). Psychosocial and behavioral impact of genetic counseling and testing. Breast Disease, 27, 97-108.
34. vanOostrom, I.,Meijers-Heijboer, H., Lodder, L. N.,Duivenvoorden, H. J., van Gool,A. R., Seynaeve, C., et al. (2003). Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: A 5-year follow-up study. Journal of Clinical Oncology, 21(20), 3867-3874.
35. Weitzel, J.N., McCaffrey, S. M.,Nedelcu, R., Mac Donald, D. J., Blazer,K. R.,& Cullinane, C. A. (2003). Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Archives of Surgery, 138(12), 1323-1328; discussion 1329.